TITLE:
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

CONDITION:
Melanoma

INTERVENTION:
PF-3512676

SUMMARY:

      This protocol allows patients who completed Coley oncology studies using PF-3512676 (CPG
      7909) Injection to continue receiving the treatment until disease progression.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

        Immediate (within 4 weeks) prior completion of a clinical trial of PF-3512676 Injection
        alone or in combination with other anti-neoplastic treatment for malignancy.

        Exclusion Criteria:

        The patient has received any anti-neoplastic therapy since completing a prior trial with
        PF-3512676 Injection, or has participated in another clinical trial following
        participation in a trial with PF-3512676 Injection.
      
